Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/85334
Author(s): | Antonio Araújo |
Title: | Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls. |
Issue Date: | 2016-09 |
URI: | https://hdl.handle.net/10216/85334 |
Document Type: | Artigo em Revista Científica Internacional |
Rights: | openAccess |
License: | https://creativecommons.org/licenses/by-nc/4.0/ |
Appears in Collections: | ICBAS - Artigo em Revista Científica Internacional |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
143041.pdf | 474.64 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License